TESARO Announces Data Presentations at ESMO 2018 Congress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Tesaro (TSRO) PT Raised to $68 at Cantor Fitzgerald Following Strong SOLO1 Data
October 22, 2018 8:51 AM EDTCantor Fitzgerald analyst Alethia Young raised the price target on Tesaro (NASDAQ: TSRO) to $68.00 (from $57.00) while maintaining an Overweight rating. Today at the European oncology meeting, AstraZeneca presented the SOLO1 study using olaparib (a PARP inhibitor) as a first-line treatment for BRCA ovarian... More
